Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer

被引:0
|
作者
H Bando
H A Weich
M Brokelmann
S Horiguchi
N Funata
T Ogawa
M Toi
机构
[1] Tokyo Metropolitan Komagome Hospital,Department of Surgery
[2] Tokyo Metropolitan Cancer and Infectious Disease Center,Department of Gene Regulation and Differentiation
[3] National Research Centre for Biotechnology,Department of Pathology
[4] Tokyo Metropolitan Komagome Hospital,Department of Clinical Trials and Research
[5] Tokyo Metropolitan Cancer and Infectious Disease Center,undefined
[6] Tokyo Metropolitan Komagome Hospital,undefined
[7] Tokyo Metropolitan Cancer and Infectious Disease Center,undefined
来源
British Journal of Cancer | 2005年 / 92卷
关键词
vascular endothelial growth factor; soluble vascular endothelial growth factor receptor-1; vascular endothelial growth factor receptor-2; neovascularisation; breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Vascular endothelial growth factor (VEGF) receptors consist of three cell-membrane type receptors (VEGFR-1, VEGFR-2 and VEGFR-3), and soluble form of VEGFR-1 (sVEGFR-1), an intrinsic negative counterpart of the VEGF. In this study, we measured intratumoral protein levels of free and total VEGF, VEGFR-2 and sVEGFR-1 from 202 primary breast cancer tissues and examined their prognostic values. A significant inverse correlation was found between free or total VEGF and oestrogen receptor (ER) status (P=0.042 and 0.032, respectively). A univariate analysis showed that low sVEGFR-1 and high total VEGF were significantly associated with poor prognosis in disease-free survival (DFS) and overall survival (OS). The ratio of sVEGFR-1 to total VEGF was a strong prognostic indicator (DFS: P=0.008; OS: P=0.0002). A multivariate analysis confirmed the independent prognostic values of total VEGF and the ratio of sVEGFR-1 to total VEGF. In subgroup analysis, total VEGF was a significant prognostic indicator for ER-positive tumours but not for ER-negative tumours, whereas sVEGFR-1 was significant for ER-negative tumours but not for ER-positive tumours. In conclusion, the intratumoral sVEGFR-1 level, VEGF level and the ratio of sVEGFR-1 to total VEGF are potent prognostic indicators of primary breast cancer, and might be relevant to ER status.
引用
收藏
页码:553 / 561
页数:8
相关论文
共 50 条
  • [1] Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
    Bando, H
    Weich, HA
    Brokelmann, M
    Horiguchi, S
    Funata, N
    Ogawa, T
    Toi, M
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (03) : 553 - 561
  • [2] Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells
    Garvin, S
    Nilsson, UW
    Dabrosin, C
    [J]. BRITISH JOURNAL OF CANCER, 2005, 93 (09) : 1005 - 1010
  • [3] Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells
    S Garvin
    U W Nilsson
    C Dabrosin
    [J]. British Journal of Cancer, 2005, 93 : 1005 - 1010
  • [4] Heterodimerisation between VEGFR-1 and VEGFR-2 and not the homodimers of VEGFR-1 inhibit VEGFR-2 activity
    Cai, Meng
    Wang, Keqing
    Murdoch, Colin E.
    Gu, Yuchun
    Ahmed, Asif
    [J]. VASCULAR PHARMACOLOGY, 2017, 88 : 11 - 20
  • [5] Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes
    Kim, I
    Ryan, AM
    Rohan, R
    Amano, S
    Agular, S
    Miller, JW
    Adamis, AP
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (09) : 2115 - 2121
  • [6] Angiogenic factors in small veil lung cancer (VEGF, VEGFR-1, VEGFR-2)
    Soydinc, Hilal Oguz
    Duranyildiz, Derya
    Bilgin, Elif
    Tas, Faruk
    Yasasever, Vildan
    [J]. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2012, 27 (02): : 55 - 61
  • [7] Expression of VEGF-A, VEGFR-1, VEGFR-2 and microvessel density in colorectral cancer with liver metastasis
    Hui, Jeong E.
    Duk, Choi Y.
    Woo, Min B.
    Hyuk, Lee J.
    [J]. VIRCHOWS ARCHIV, 2009, 455 : 117 - 117
  • [8] Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma
    Meunier-Carpentier, S
    Dales, JP
    Djemli, A
    Garcia, S
    Bonnier, P
    Andrac-Meyer, L
    Lavaut, MN
    Allasia, C
    Charpin, C
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (04) : 977 - 984
  • [9] Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
    Nascimento, Catarina
    Gameiro, Andreia
    Ferreira, Joao
    Correia, Jorge
    Ferreira, Fernando
    [J]. CANCERS, 2021, 13 (01)
  • [10] Intratumoral Poems and Expression of VEGF, VEGFR-1 and VEGFR-2 in different subtypes of primary cutaneous B-cell lymphoma
    Wobser, Marion
    Siedel, Claudia
    Broecker, Eva-Bettina
    Goebeler, Matthias
    Houben, Roland
    Geissinger, Eva
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (09): : 676 - 676